Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:53 AM
Ignite Modification Date:
2025-12-25 @ 3:53 AM
NCT ID:
NCT00824902
Eligibility Criteria:
Inclusion Criteria:
1. Patients selected for radical prostatectomy (any technique) at MDACC
2. Histologic diagnosis of prostate cancer, clinical stage cT1c-cT3b
3. Serum prostate specific antigen less than 30 ng/ml.
4. Any Gleason score
5. Total prostate volume of 20-60 cc, measured by outside ultrasound or clinical examination at MDACC.
6. Group 1: high volume disease. At least 3 positive cores containing cancer on one side of the prostate Group 2: low volume disease. Less than 50% tumor length in a single positive core on one side of the prostate
Exclusion Criteria:
1. Prior radiation therapy to the pelvis
2. Prior hormonal therapy within 3 months (including LH/RH agonists, estrogens, testosterone receptor blockade, finasteride, dutasteride)
Healthy Volunteers:
False
Sex:
MALE
Study:
NCT00824902
Study Brief:
Protocol Section:
NCT00824902